A Study of SCAD Using Stress Contrast Echocardiography

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This study aims to fill knowledge gaps regarding microvascular perfusion and pressor response to stress among patients with history of spontaneous coronary artery dissection (SCAD) using stress contrast echocardiography.

Eligibility criteria

Qualifiers

Adult >18 years old

Patient has a history of spontaneous coronary artery dissection (SCAD) OR patient is healthy with no significant medical history

Disqualifiers

Unable to give consent

Allergic or have a history of adverse reaction to dobutamine, the Definity® ultrasound enhancing agent, or atropine.

Has a known or suspected hypersensitivity to perflutren and therefore cannot be given Definity®.

Pregnant.

Trial design

Treatments tested in this trial

  • Stress Echocardiography with Contrast

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Mayo Clinic

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator